Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
Status:
Completed
Trial end date:
2002-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of oxaliplatin plus irinotecan in treating
patients with previously treated metastatic gastrointestinal cancer that has not responded to
previous treatment.